These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 9178473

  • 1. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE).
    Garcia-Valcarcel M, Fowler WJ, Harper DR, Jeffries DJ, Layton GT.
    Vaccine; 1997; 15(6-7):709-19. PubMed ID: 9178473
    [Abstract] [Full Text] [Related]

  • 2. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus.
    Fowler WJ, Garcia-Valcarcel M, Hill-Perkins MS, Murphy G, Harper DR, Jeffries DJ, Burns NR, Adams SE, Kingsman AJ, Layton GT.
    Virology; 1995 Dec 20; 214(2):531-40. PubMed ID: 8553555
    [Abstract] [Full Text] [Related]

  • 3. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD, Harper DR, Garcia-Valcarcel M, Fowler WJ, Aitken C, Jeffries DJ, Layton GT.
    J Med Virol; 1999 Sep 20; 59(1):78-83. PubMed ID: 10440812
    [Abstract] [Full Text] [Related]

  • 4. A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice.
    Zhu R, Liu J, Chen C, Ye X, Xu L, Wang W, Zhao Q, Zhu H, Cheng T, Xia N.
    Vaccine; 2016 Mar 18; 34(13):1589-1596. PubMed ID: 26873057
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
    Jacquet A, Haumont M, Massaer M, Garcia L, Mazzu P, Daminet V, Grégoire D, Jacobs P, Bollen A.
    Vaccine; 2002 Feb 22; 20(11-12):1593-602. PubMed ID: 11858867
    [Abstract] [Full Text] [Related]

  • 6. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
    Bergen RE, Sharp M, Sanchez A, Judd AK, Arvin AM.
    Viral Immunol; 1991 Feb 22; 4(3):151-66. PubMed ID: 1725699
    [Abstract] [Full Text] [Related]

  • 7. Characterization of neutralizing domains on varicella-zoster virus glycoprotein E defined by monoclonal antibodies.
    Wu L, Forghani B.
    Arch Virol; 1997 Feb 22; 142(2):349-62. PubMed ID: 9125048
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stability of a varicella-zoster virus glycoprotein E epitope.
    Vafai A, Forghani B, Kilpatrick D, Ling J, Shankar V.
    Arch Virol; 2000 Feb 22; 145(1):85-97. PubMed ID: 10664408
    [Abstract] [Full Text] [Related]

  • 14. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.
    Haumont M, Jurdan M, Kangro H, Jacquet A, Massaer M, Deleersnyder V, Garcia L, Bosseloir A, Bruck C, Bollen A, Jacobs P.
    J Med Virol; 1997 Sep 22; 53(1):63-8. PubMed ID: 9298734
    [Abstract] [Full Text] [Related]

  • 15. Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice.
    Wui SR, Kim KS, Ryu JI, Ko A, Do HTT, Lee YJ, Kim HJ, Lim SJ, Park SA, Cho YJ, Kim CG, Lee NG.
    Vaccine; 2019 Apr 03; 37(15):2131-2141. PubMed ID: 30827737
    [Abstract] [Full Text] [Related]

  • 16. Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain.
    Santos RA, Padilla JA, Hatfield C, Grose C.
    Virology; 1998 Sep 15; 249(1):21-31. PubMed ID: 9740773
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
    Pan Q, Wang H, Ouyang W, Wang X, Bi Z, Xia X, Wang Y, He K.
    Vaccine; 2016 Jan 20; 34(4):578-585. PubMed ID: 26685093
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.